PCSK9 (involve in regulating blood cholesterol) inhibitors can significantly lower LDL and plasma Lp(a) (55, 56) and reduce the risk of cardiovascular disease, but have an unclear impact on calcific AS. The gene discussed is PCSK9; the disease is aortic valve stenosis.